179 related articles for article (PubMed ID: 17994191)
1. Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats.
Iñiguez SD; Cortez AM; Crawford CA; McDougall SA
J Neural Transm (Vienna); 2008; 115(1):97-106. PubMed ID: 17994191
[TBL] [Abstract][Full Text] [Related]
2. Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.
Yoshida ST; Baella SA; Stuebner NM; Crawford CA; McDougall SA
Brain Res; 2006 Feb; 1073-1074():269-75. PubMed ID: 16427034
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
[TBL] [Abstract][Full Text] [Related]
4. Pre- and postsynaptic actions of a partial D2 receptor agonist in reserpinized young rats: longevity of agonistic effects.
Farley CM; Baella SA; Wacan JJ; Crawford CA; McDougall SA
Brain Res; 2006 Dec; 1124(1):37-44. PubMed ID: 17070785
[TBL] [Abstract][Full Text] [Related]
5. The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.
McDougall SA; Hernandez RM; Reichel CM; Farley CM
Psychopharmacology (Berl); 2005 Apr; 178(4):431-9. PubMed ID: 15765258
[TBL] [Abstract][Full Text] [Related]
6. The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen.
Wacan JJ; Reichel CM; Farley CM; McDougall SA
Psychopharmacology (Berl); 2006 Mar; 185(1):104-11. PubMed ID: 16447063
[TBL] [Abstract][Full Text] [Related]
7. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
Ma GF; Raivio N; Sabrià J; Ortiz J
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
[TBL] [Abstract][Full Text] [Related]
9. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
[TBL] [Abstract][Full Text] [Related]
10. Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats.
Sibole JM; Matea PJ; Krall CM; McDougall SA
Pharmacol Biochem Behav; 2003 Aug; 76(1):27-34. PubMed ID: 13679214
[TBL] [Abstract][Full Text] [Related]
11. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.
Koener B; Goursaud S; Van De Stadt M; Calas AG; Jeanjean AP; Maloteaux JM; Hermans E
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):65-77. PubMed ID: 21061116
[TBL] [Abstract][Full Text] [Related]
13. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
Li Z; Ichikawa J; Dai J; Meltzer HY
Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission.
Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
Neuropharmacology; 2012 Feb; 62(2):765-74. PubMed ID: 21925189
[TBL] [Abstract][Full Text] [Related]
16. Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.
Der-Ghazarian T; Widarma CB; Gutierrez A; Amodeo LR; Valentine JM; Humphrey DE; Gonzalez AE; Crawford CA; McDougall SA
Psychopharmacology (Berl); 2014 Feb; 231(4):651-62. PubMed ID: 24057816
[TBL] [Abstract][Full Text] [Related]
17. Repeated aripiprazole treatment causes dopamine D2 receptor up-regulation and dopamine supersensitivity in young rats.
Varela FA; Der-Ghazarian T; Lee RJ; Charntikov S; Crawford CA; McDougall SA
J Psychopharmacol; 2014 Apr; 28(4):376-86. PubMed ID: 24045880
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of 2-bromoterguride at human dopamine D2, porcine serotonin 5-hydroxytryptamine 2A, and α2C-adrenergic receptors, and its antipsychotic-like effects in rats.
Jantschak F; Brosda J; Franke RT; Fink H; Möller D; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2013 Oct; 347(1):57-68. PubMed ID: 23863695
[TBL] [Abstract][Full Text] [Related]
19. Partial agonists in schizophrenia--why some work and others do not: insights from preclinical animal models.
Natesan S; Reckless GE; Barlow KB; Nobrega JN; Kapur S
Int J Neuropsychopharmacol; 2011 Oct; 14(9):1165-78. PubMed ID: 21087552
[TBL] [Abstract][Full Text] [Related]
20. In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
Jordan S; Regardie K; Johnson JL; Chen R; Kambayashi J; McQuade R; Kitagawa H; Tadori Y; Kikuchi T
J Psychopharmacol; 2007 Aug; 21(6):620-7. PubMed ID: 17092971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
